Quoting Ipsos data, the company said the Herceptin and its biosimilars had India sales of Rs 290 crore for the most recent 12 months ending in December 2017.from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2NGwYm8
via IFTTT
Dr Reddy's launches Hervycta to treat cancer in India
Quoting Ipsos data, the company said the Herceptin and its biosimilars had India sales of Rs 290 crore for the most recent 12 months ending in December 2017.from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2NGwYm8
via IFTTT
0 comments:
Post a Comment